Description: Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.
Home Page: www.starrypharm.com
Xianju modern industrial cluster
Xianju,
317300
China
Phone:
86 57 6877 18628
Officers
| Name | Title |
|---|---|
| Mr. Jian Hu | GM, Acting Sec. of the Board of Directors & Director |
| Mr. Wei Ding | Financial Mang. |
| Mr. Qinhu Fang | Deputy Gen. Mang. |
| Ms. Wenjun Lu | Deputy Gen. Mang. |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 57.6667 |
| Price-to-Book MRQ: | 3.5476 |
| Price-to-Sales TTM: | 3.3356 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1818 |